Intuitive Surgical AI Push And Global Expansion Tested By Rich Valuation

Intuitive Surgical AI Push And Global Expansion Tested By Rich Valuation

Simply Wall St

Tue, February 17, 2026 at 6:10 AM GMT+9 3 min read

In this article:

ISRG

Find your next quality investment with Simply Wall Stโ€™s easy and powerful screener, trusted by over 7 million individual investors worldwide.

Intuitive Surgical is integrating artificial intelligence into its robotic surgery systems across its platforms.
The company reports strong global procedure volumes and continued growth in minimally invasive surgery adoption.
Recent investments are focused on expanding direct operations and deepening its presence in key European markets.

For investors watching NasdaqGS:ISRG, the story is not just about surgical robots; it is about how those systems are being upgraded with AI and scaled worldwide. The shares last closed at $485.84, with a 3 year return of 103.4% and a 5 year return of 96.6%, which gives useful context around how the market has historically valued the companyโ€™s progress in robotic assisted care.

What stands out in the latest updates is the mix of product development, heavier research spending, and a bigger operational footprint in Europe. For you as an investor, these moves frame Intuitive Surgical as a company working to deepen the clinical relevance of its systems and widen access to its platforms, factors that can shape how its role in the medtech space evolves over time.

Stay updated on the most important news stories for Intuitive Surgical by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Intuitive Surgical.

NasdaqGS:ISRG Earnings & Revenue Growth as at Feb 2026

3 things going right for Intuitive Surgical that this headline doesnโ€™t cover.

Investor Checklist

Quick Assessment

**โœ… Price vs Analyst Target**: The current price of US$485.84 sits about 21% below the US$611.82 analyst target, with a published range from US$378 to US$750.
**โŒ Simply Wall St Valuation**: Shares are described as trading 28.4% above estimated fair value, so the price is rich relative to that model.
**โŒ Recent Momentum**: The 30 day return of about 9.2% decline flags short term weakness despite the positive news flow.

There is only one way to know the right time to buy, sell or hold Intuitive Surgical. Head to Simply Wall Stโ€™s company report for the latest analysis of Intuitive Surgicalโ€™s Fair Value.

Key Considerations

๐Ÿ“Š AI integration, strong global procedure volumes and investment in direct operations suggest the business is leaning into its strengths in minimally invasive care.
๐Ÿ“Š With a P/E of about 60.4 versus a Medical Equipment peer average near 30.4, you may want to track how earnings, procedure growth and AI adoption progress against that premium.
โš ๏ธ The combination of a 28.4% premium to estimated fair value and a recent 9.2% decline in the share price raises the risk of further volatility if expectations are not met.

 






Story Continues  

Dig Deeper

For the full picture including more risks and rewards, check out the complete Intuitive Surgical analysis. Alternatively, you can check out the community page for Intuitive Surgical to see how other investors believe this latest news will impact the companyโ€™s narrative.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include ISRG.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments